This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Chisaka, H. Articles by Challis, J. R.G. Search for Related Content PubMed PubMed Citation Articles by Chisaka, H. Articles by Johnstone, J. F. Articles by Premyslova, M. Articles by Manduch, Z. Articles by Challis, J. R.G. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB HYDROCORTISONE Medline Plus Health Information Pregnancy Social Bookmarking                   What's this?

Effect of Pro-inflammatory Cytokines on Expression and Activity of 11ß-Hydroxysteroid Dehydrogenase Type 2 in Cultured Human Term Placental Trophoblast and Human Choriocarcinoma JEG-3 Cells

CIHR Group in Development and Fetal Health, Department of Physiology and Obstetrics, Gynecology and Medicine, University of Toronto, Toronto, Ontario, Canada h.chisaka{at}utoronto.ca

Jim F. Johnstone, MSc

Manrina Premyslova, PhD

Zuzka Manduch, BSc

John R.G. Challis, PhD, DSc

CIHR Group in Development and Fetal Health, Department of Physiology and Obstetrics, Gynecology and Medicine, University of Toronto, Toronto, Ontario, Canada

Objective: 1 ß-Hydroxysteroid dehydrogenase type 2 (11ß-HSD2) is thought to act as a placental barrier protecting the fetus from high levels of maternal cortisol. On the other hand, intrauterine infection is one of the main causes of preterm birth and adverse fetal outcome, and pro-inflammatory cytokines may contribute to these adverse effects. However, the effect of pro-inflammatory cytokines on 11ß-HSD2 is still not clear. Therefore, we have evaluated the effect of tumor necrosisfactor- (TNF-) and interleukin-1ß (IL-1ß) on 11ß-HSD2 in cultured human placental trophoblast and in human choriocarcinoma JEG-3 cells.

Methods: Placental trophoblast cells were isolatedfrom human term placenta. Placental trophoblast cells and JEG-3 cells were treated with TNF- (0.1-10 ng/mL) or IL-1ß (0.1-10 ng/mL). Real-time reverse transcription polymerase chain reaction and Western blot were used to study the regulation of 1 11ß-HSD2 expression. 11ß-HSD2 activity was determined by measuring the rate of cortisol to cortisone conversion in the culture medium using thin-layer chromatography (TLC).

Results: In placental trophoblast, TNF- and IL-1ß down-regulated 11ß-HSD2 mRNA expression and activity (both P <.05). The protein level was decreased only with IL-1ß (P <.05). In JEG-3 cells, 11ß-HSD2 mRNA was decreased by TNF- but up-regulated by IL-1ß, with no significant change in protein expression and activity.

Conclusion: Our results suggest caution in interpreting data using JEG-3 cells. However, our studies with primary trophoblast suggest that TNF- and IL-1ß may increase the amount of cortisol crossing to the placenta and fetal circulation by attenuating 11ß-HSD2 activity, potentially contributing to preterm labor and altered fetal outcome in uterine infection.

Key Words: 11ß-HSD2 • intrauterine infection • pro-inflammatory cytokines • human placental trophoblast • JEG-3 cells

Journal of the Society for Gynecologic Investigation, Vol. 12, No. 5, 303-309 (2005)
DOI: 10.1016/j.jsgi.2005.02.003


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?